YAP1 and non-small cell lung carcinoma: Recently, Ning et al.100demonstrated that CA3 (a novel inhibitor of YAP1), in combination with Osimertinib, inhibits NSCLC cell proliferation and metastasis by induction of autophagy and cell apoptosis.